Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Steve Chesney is an analyst at Redburn Atlantic. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/27/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/27/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $503.00 | 8.35% | Steve Chesney55% | → $545 | Initiates | → Buy | Get Alert |
| 02/06/2024 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | -8.34% | Steve Chesney55% | $77 → $54 | Downgrade | Buy → Neutral | Get Alert |
| 08/08/2023 | BIIB | Buy Now | Biogen | $140.33 | 95.97% | Steve Chesney55% | $282 → $275 | Maintains | Neutral | Get Alert |
| 08/04/2023 | JNJ | Buy Now | Johnson & Johnson | $163.40 | 4.04% | Steve Chesney55% | $167 → $170 | Maintains | Neutral | Get Alert |
| 08/02/2023 | IDXX | Buy Now | IDEXX Laboratories | $422.54 | 42% | Steve Chesney55% | → $600 | Downgrade | Overweight → Neutral | Get Alert |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | 44.28% | Steve Chesney55% | $90 → $85 | Maintains | Overweight | Get Alert |
| 06/14/2023 | ZTS | Buy Now | Zoetis | $165.02 | 36.35% | Steve Chesney55% | → $225 | Reiterates | Overweight → Overweight | Get Alert |
| 06/07/2023 | IDXX | Buy Now | IDEXX Laboratories | $422.54 | 42% | Steve Chesney55% | → $600 | Reiterates | Overweight → Overweight | Get Alert |
| 05/26/2023 | ZTS | Buy Now | Zoetis | $165.02 | 36.35% | Steve Chesney55% | → $225 | Reiterates | Overweight → Overweight | Get Alert |
| 05/03/2023 | IDXX | Buy Now | IDEXX Laboratories | $422.54 | 42% | Steve Chesney55% | → $600 | Reiterates | → Overweight | Get Alert |
| 05/01/2023 | MRK | Buy Now | Merck & Co | $87.69 | 47.11% | Steve Chesney55% | $127 → $129 | Maintains | Overweight | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $140.33 | 100.95% | Steve Chesney55% | $295 → $282 | Maintains | Neutral | Get Alert |
| 04/19/2023 | JNJ | Buy Now | Johnson & Johnson | $163.40 | 2.2% | Steve Chesney55% | $168 → $167 | Maintains | Neutral | Get Alert |
| 03/07/2023 | MRK | Buy Now | Merck & Co | $87.69 | 44.83% | Steve Chesney55% | $122 → $127 | Maintains | Overweight | Get Alert |
| 02/10/2023 | ABBV | Buy Now | AbbVie | $202.65 | -24.01% | Steve Chesney55% | $157 → $154 | Maintains | Neutral | Get Alert |
| 02/07/2023 | IDXX | Buy Now | IDEXX Laboratories | $422.54 | 42% | Steve Chesney55% | $470 → $600 | Maintains | Overweight | Get Alert |
| 02/03/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | 52.77% | Steve Chesney55% | $88 → $90 | Maintains | Overweight | Get Alert |
| 02/01/2023 | PFE | Buy Now | Pfizer | $25.06 | 83.56% | Steve Chesney55% | $50 → $46 | Maintains | Neutral | Get Alert |
| 01/25/2023 | JNJ | Buy Now | Johnson & Johnson | $163.40 | 2.82% | Steve Chesney55% | $160 → $168 | Maintains | Neutral | Get Alert |
| 12/01/2022 | BIIB | Buy Now | Biogen | $140.33 | 110.22% | Steve Chesney55% | $220 → $295 | Maintains | Neutral | Get Alert |
| 11/10/2022 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | 49.37% | Steve Chesney55% | $85 → $88 | Maintains | Overweight | Get Alert |
| 11/02/2022 | IDXX | Buy Now | IDEXX Laboratories | $422.54 | 11.23% | Steve Chesney55% | $490 → $470 | Maintains | Overweight | Get Alert |
| 10/31/2022 | ABBV | Buy Now | AbbVie | $202.65 | -22.53% | Steve Chesney55% | $162 → $157 | Maintains | Neutral | Get Alert |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $87.69 | 39.13% | Steve Chesney55% | $116 → $122 | Maintains | Overweight | Get Alert |
| 10/27/2022 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | 44.28% | Steve Chesney55% | $87 → $85 | Maintains | Overweight | Get Alert |
| 10/26/2022 | BIIB | Buy Now | Biogen | $140.33 | 56.77% | Steve Chesney55% | $200 → $220 | Maintains | Neutral | Get Alert |
| 10/19/2022 | JNJ | Buy Now | Johnson & Johnson | $163.40 | -2.08% | Steve Chesney55% | $165 → $160 | Maintains | Neutral | Get Alert |
| 10/11/2022 | MRK | Buy Now | Merck & Co | $87.69 | 32.29% | Steve Chesney55% | $110 → $116 | Maintains | Overweight | Get Alert |
| 09/12/2022 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | 47.67% | Steve Chesney55% | $83 → $87 | Maintains | Overweight | Get Alert |
| 08/09/2022 | AMGN | Buy Now | Amgen | $304.52 | -40.23% | Steve Chesney55% | $190 → $182 | Maintains | Underweight | Get Alert |
| 08/03/2022 | IDXX | Buy Now | IDEXX Laboratories | $422.54 | 15.97% | Steve Chesney55% | $500 → $490 | Maintains | Overweight | Get Alert |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $202.65 | -20.06% | Steve Chesney55% | $178 → $162 | Maintains | Neutral | Get Alert |
| 07/28/2022 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | 40.88% | Steve Chesney55% | $82 → $83 | Maintains | Overweight | Get Alert |
| 07/20/2022 | JNJ | Buy Now | Johnson & Johnson | $163.40 | 0.98% | Steve Chesney55% | $174 → $165 | Maintains | Neutral | Get Alert |
| 07/13/2022 | MRK | Buy Now | Merck & Co | $87.69 | 25.45% | Steve Chesney55% | $105 → $110 | Maintains | Overweight | Get Alert |
| 02/08/2022 | IDXX | Buy Now | IDEXX Laboratories | $422.54 | 53.83% | Steve Chesney55% | → $650 | Initiates | → Overweight | Get Alert |
| 04/28/2021 | AMGN | Buy Now | Amgen | $304.52 | -34.32% | Steve Chesney55% | → $200 | Downgrade | Neutral → Underweight | Get Alert |
| 11/09/2020 | BIIB | Buy Now | Biogen | $140.33 | 24.71% | Steve Chesney55% | → $175 | Downgrade | Neutral → Underweight | Get Alert |
| 10/12/2020 | PFE | Buy Now | Pfizer | $25.06 | 55.63% | Steve Chesney55% | $44 → $39 | Downgrade | Overweight → Neutral | Get Alert |
| 06/23/2020 | ABBV | Buy Now | AbbVie | $202.65 | -43.25% | Steve Chesney55% | → $115 | Upgrade | Neutral → Overweight | Get Alert |
| 10/16/2019 | JNJ | Buy Now | Johnson & Johnson | $163.40 | — | Steve Chesney55% | — | Upgrade | Underweight → Neutral | Get Alert |
| 08/14/2019 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | — | Steve Chesney55% | — | Upgrade | Neutral → Overweight | Get Alert |
| 03/21/2019 | BIIB | Buy Now | Biogen | $140.33 | — | Steve Chesney55% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/08/2018 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | — | Steve Chesney55% | — | Upgrade | Underweight → Neutral | Get Alert |
| 02/05/2018 | AMGN | Buy Now | Amgen | $304.52 | — | Steve Chesney55% | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/21/2017 | JNJ | Buy Now | Johnson & Johnson | $163.40 | — | Steve Chesney55% | — | Downgrade | Neutral → Underweight | Get Alert |
| 12/18/2015 | JNJ | Buy Now | Johnson & Johnson | $163.40 | -41.86% | Steve Chesney55% | → $95 | Initiates | → Neutral | Get Alert |
| 12/18/2015 | ABBV | Buy Now | AbbVie | $202.65 | -70.89% | Steve Chesney55% | → $59 | Initiates | → Neutral | Get Alert |
| 12/18/2015 | PFE | Buy Now | Pfizer | $25.06 | 55.63% | Steve Chesney55% | → $39 | Initiates | → Overweight | Get Alert |
| 12/18/2015 | BMY | Buy Now | Bristol-Myers Squibb | $58.91 | -3.25% | Steve Chesney55% | → $57 | Initiates | → Underweight | Get Alert |
| 12/18/2015 | AMGN | Buy Now | Amgen | $304.52 | -33.67% | Steve Chesney55% | → $202 | Initiates | → Overweight | Get Alert |
| 12/18/2015 | BIIB | Buy Now | Biogen | $140.33 | 145.14% | Steve Chesney55% | → $344 | Initiates | → Overweight | Get Alert |
| 01/27/2014 | PFE | Buy Now | Pfizer | $25.06 | 45.65% | Steve Chesney55% | $37 → $36.5 | Maintains | Overweight | Get Alert |
